Alzheimer’s drug from Eisai and Biogen slows cognitive decline, side-effects in focus
A test tube is seen in front of the displayed Biogen logo in this illustration taken, on December 1, 2021. | Photo Credit: Reuters An experimental Alzheimer’s disease drug from Eisai and Biogen slowed cognitive decline in a closely watched trial but may carry a risk of dangerous side effects for certain patients, according to […]
Continue Reading
